Inventor · disambiguated record
Katie Olson Anderson
Also filed as: ANDERSON KATIE · ANDERSON KATIE OLSON
38 granted patents·11 pending applications·263 citations·filing 2010–2023
98Inventor score
Files withALDERBIO HOLDINGS LLC38ALDER BIOPHARMACEUTICALS INC4H LUNDBECK AS4ALDERIBIO HOLDINGS LLC1GARCIA-MARTINEZ LEON F1
Top patents by PatentIndex Score
49 records- 0198US10533048B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Jan 14, 2020·11 cites·30 claims
- 0297US10066009B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2016·Granted Sep 4, 2018·19 cites·30 claims
- 0396US10179809B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Jan 15, 2019·13 cites·30 claims
- 0496US9884912B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2014·Granted Feb 6, 2018·15 cites·13 claims
- 0596US9255154B2Anti-PCSK9 antibodies and use thereofALDERBIO HOLDINGS LLC·Filed 2013·Granted Feb 9, 2016·36 cites·20 claims
- 0696US9085615B2Antibodies to IL-6 to inhibit or treat inflammationALDERBIO HOLDINGS LLC·Filed 2012·Granted Jul 21, 2015·29 cites·32 claims
- 0795US10214582B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Feb 26, 2019·12 cites·30 claims
- 0895US10208112B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Feb 19, 2019·12 cites·30 claims
- 0995US10189895B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Jan 29, 2019·12 cites·29 claims
- 1095US9481725B2Antibodies to HGF and compositions containingALDERBIO HOLDINGS LLC·Filed 2014·Granted Nov 1, 2016·16 cites·11 claims
- 1194US10100108B2Antibodies to HGF and compositions containingALDERBIO HOLDINGS LLC·Filed 2016·Granted Oct 16, 2018·6 cites·20 claims
- 1294US9834603B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2015·Granted Dec 5, 2017·7 cites·11 claims
- 1393US9725509B2Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibodyALDERBIO HOLDINGS LLC·Filed 2015·Granted Aug 8, 2017·9 cites·34 claims
- 1492US9783603B2Therapeutic use of antibodies to HGFALDERBIO HOLDINGS LLC·Filed 2015·Granted Oct 10, 2017·5 cites·14 claims
- 1592US9062104B2Therapeutic use of antibodies to HGFALDERBIO HOLDINGS LLC·Filed 2013·Granted Jun 23, 2015·10 cites·17 claims
- 1691US11427631B2Anti-ACTH antibodies and use thereofH LUNDBECK AS·Filed 2020·Granted Aug 30, 2022·2 cites·26 claims
- 1790US9879074B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2015·Granted Jan 30, 2018·4 cites·18 claims
- 1889US10391169B2Method of treating allergic asthma with antibodies to IL-6ALDERBIO HOLDINGS LLC·Filed 2017·Granted Aug 27, 2019·4 cites·10 claims
- 1988US11117960B2Humanized anti-ACTH antibodies and use thereofALDERBIO HOLDINGS LLC·Filed 2019·Granted Sep 14, 2021·2 cites·26 claims
- 2088US10913794B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2017·Granted Feb 9, 2021·2 cites·11 claims
- 2188US2024174738A1Anti-cgrp compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 2287US9771421B2Treating anemia in chronic IL-6 associated diseases using anti-IL-6 antibodiesALDERBIO HOLDINGS LLC·Filed 2015·Granted Sep 26, 2017·5 cites·20 claims
- 2386US10259885B2Anti-PCSK9 antibodies and use thereofALDERBIO HOLDINGS LLC·Filed 2015·Granted Apr 16, 2019·4 cites·21 claims
- 2486US10117955B2Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodiesALDERBIO HOLDINGS LLC·Filed 2016·Granted Nov 6, 2018·3 cites·19 claims
- 2585US10800841B2Methods of treating autoimmunity using specific anti-IL-6 antibodiesALDERBIO HOLDINGS LLC·Filed 2017·Granted Oct 13, 2020·2 cites·17 claims
- 2685US9775921B2Subcutaneously administrable composition containing anti-IL-6 antibodyGARCIA-MARTINEZ LEON F·Filed 2010·Granted Oct 3, 2017·9 cites·14 claims
- 2783US10544214B2Humanized anti-ACTH antibodies and use thereofALDER BIOPHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·2 cites·20 claims
- 2883US9732150B2Therapeutic use of antibodies to HGFALDERBIO HOLDINGS LLC·Filed 2014·Granted Aug 15, 2017·6 cites·17 claims
- 2982US12351627B2Anti-ACTH antibodies and use thereofH LUNDBECK AS·Filed 2022·Granted Jul 8, 2025·0 cites·13 claims
- 3081US10550180B2Anti-ACTH antibodies and use thereofALDERBIO HOLDINGS LLC·Filed 2017·Granted Feb 4, 2020·2 cites·8 claims
- 3181US10047157B2Humanized anti-ACTH antibodies and use thereofALDER BIOPHARMACEUTICALS INC·Filed 2015·Granted Aug 14, 2018·2 cites·11 claims
- 3279US9688754B2Anti-ACTH antibodies and use thereofALDER BIOPHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·2 cites·8 claims
- 3378US12428475B2Humanized anti-ACTH antibodies and use thereofH LUNDBECK AS·Filed 2021·Granted Sep 30, 2025·0 cites·30 claims
- 3474US2021047391A1Anti-cgrp compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 3573US11111289B2Anti-CGRP compositions and use thereofH LUNDBECK AS·Filed 2019·Granted Sep 7, 2021·0 cites·16 claims
- 3671US11827700B2Treatment or prevention of diseases and disorders associated with cells that express IL-6 with Anti-IL-6 antibodiesVITAERIS INC·Filed 2020·Granted Nov 28, 2023·0 cites·20 claims
- 3771US2020108140A1Antibodies to il-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2019·Application pending·0 cites
- 3871US2020087391A1Antibodies to il-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2019·Application pending·0 cites
- 3970US2020040074A1Antibodies to il-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2019·Application pending·0 cites
- 4068US10759853B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2017·Granted Sep 1, 2020·0 cites·17 claims
- 4168US10344086B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2017·Granted Jul 9, 2019·0 cites·21 claims
- 4268US10233239B2Isolated host cells expressing anti-IL-6 antibodiesALDERBIO HOLDINGS LLC·Filed 2017·Granted Mar 19, 2019·0 cites·14 claims
- 4360US9890214B2Antibodies to TNF α and use thereofALDERBIO HOLDINGS LLC·Filed 2015·Granted Feb 13, 2018·0 cites·8 claims
- 4459US2018201668A1In vivo Imaging using Anti-IL-6 AntibodiesALDERBIO HOLDINGS LLC·Filed 2017·Application pending·0 cites
- 4558US2019389968A1Anti-pcsk9 antibodies and use thereofALDERIBIO HOLDINGS LLC·Filed 2019·Application pending·0 cites
- 4658US2019085066A1Antibodies to hgf and compositions containingALDERBIO HOLDINGS LLC·Filed 2018·Application pending·0 cites
- 4757US2014287952A1Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigensALDERBIO HOLDINGS LLC·Filed 2014·Application pending·0 cites
- 4856US2016033504A1Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigensALDER BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4950US2019083665A1Antibodies to il-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →